Methods of modulating pharmacokinetics of oligonucleotides

   
   

2-O-(2-Methylthioethyl), has been incorporated into oligonucleotides and evaluated for antisense properties in comparison with the known 2-O-(2-methoxyethyl) 2-O-MOE modification. The 2-O-MTE modified oligonucleotides exhibit improved binding to human serum albumin compared with the 2-O-MOE modified oligonucleotides and maintain high binding affinity to target RNA.

 
Web www.patentalert.com

< Laser amplifying system

< Reinforced carbon nanotubes

> System and method of optimal waveform shaping

> Nanoparticles having oligonucleotides attached thereto and uses therefor

~ 00196